Aemetis Q2 2026: Operational Gains Emerge, But Debt Crisis Looms

What happened

Aemetis reported second-quarter 2026 results featuring 20% revenue growth, positive operating income, and increased dairy RNG production, signaling operational progress. However, the company’s balance sheet remains severely stressed with over $286 million in current debt and negative equity, keeping going-concern risks acute. The positive operating income, if recurring, could ease some liquidity pressure, but it is unlikely to cover high interest costs and looming maturities without fresh capital. Dairy RNG expansion offers a higher-margin growth avenue, yet its scale is still dwarfed by the overall debt burden. While these results hint at a potential operational turnaround, the financial structure demands cautious interpretation.

Implication

The Q2 2026 results, with 20% revenue growth and positive operating income, suggest Aemetis’ dairy RNG ramp and cost controls are beginning to deliver, potentially supporting cash flow if sustained across future quarters. Nonetheless, with over $286 million of current debt and negative equity, the company still faces a refinancing cliff and interest costs that could consume any operating profits, leaving shareholders at risk of dilution or wipeout. Investors should monitor subsequent quarters for confirmation of sustained profitability and concrete deleveraging steps, such as asset sales or a successful India IPO. Policy support for RNG and low-carbon fuels remains a tailwind, but the balance sheet is the dominant factor driving the binary risk/reward profile. As such, any position should be sized for a distressed scenario, with a close watch on liquidity events.

Thesis delta

The Q2 2026 positive operating income and revenue growth introduce a potential operational inflection that was not present in the prior STRONG SELL thesis. However, the overwhelming debt load and refinancing risks persist, meaning the equity remains a deeply distressed, option-like claim with only a modestly higher probability of survival. The thesis shifts from pure impairment to a fragile turnaround bet contingent on sustained cash flow improvement and balance sheet repair.